Jack Hoppin

Jack Hoppin is a seasoned professional in the biotechnology and precision medicine sectors, with a career spanning over two decades. Currently serving as CEO of Ratio Therapeutics since October 2021, Hoppin previously held the position of President at Konica Minolta Precision Medicine from January 2020 to February 2021, and co-founded inviCRO, LLC, where Hoppin served as Managing Partner from November 2008 to January 2020. Earlier experience includes roles as VP of Imaging Systems at Bioscan, Inc. from 2005 to 2008, and as a Humboldt Post-Doctoral Fellow at Forschungszentrum Jülich from 2003 to 2005. Hoppin holds a PhD in Applied Mathematics from the University of Arizona and a BA in Mathematics from the College of the Holy Cross.